CareTrust REIT, Inc. (CTRE)
NYSE: CTRE · Real-Time Price · USD
37.41
+0.09 (0.24%)
Sep 25, 2026, 4:00 PM EDT - Market closed
CareTrust REIT Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, CareTrust REIT stock has a consensus rating of "Strong Buy" and an average price target of $45.15. The average 1-year stock price forecast is 20.69% higher than the current stock price, while the lowest is $43 (+14.94%) and the highest is $49 (+30.98%).
Price Target: $45.15 (+20.69%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CareTrust REIT stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 8 | 9 | 10 | 10 | 10 |
| Buy | 2 | 2 | 3 | 3 | 2 | 2 |
| Hold | 1 | 1 | 1 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| KeyBanc | KeyBanc | Buy Reiterates $46 | Buy | Reiterates | $46 | +22.96% | Sep 16, 2026 |
Unknown Analyst Huntington Capital Markets No rating | Huntington Capital Markets | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Sep 10, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $47 → $44 | Buy | Reiterates | $47 → $44 | +17.62% | Sep 1, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Reiterates $48 | Buy | Reiterates | $48 | +28.31% | Aug 21, 2026 |
| RBC Capital | RBC Capital | Hold Downgrades $44 → $43 | Hold | Downgrades | $44 → $43 | +14.94% | Aug 14, 2026 |
Financial Forecast
Revenue This Year
619.01M
from 476.39M
Increased by 29.94%
Revenue Next Year
777.83M
from 619.01M
Increased by 25.66%
EPS This Year
1.73
from 1.36
Increased by 27.51%
EPS Next Year
1.77
from 1.73
Increased by 2.54%
EPS based on non-GAAP adjusted numbers.